QUALITY OF LIFE IN PATIENTS WITH ACTIVE NONRADIOGRAPHIC AXIAL SPONDYLOARTHRITIS AFTER 16 WEEKS OF GOLIMUMAB TREATMENT

被引：0

作者：

Maksymowych, W. P. ^{[1
]}

Curtis, S. ^{[2
]}

Dougados, M. ^{[3
]}

Bergman, G. ^{[2
]}

Huyck, S. ^{[2
]}

Tzontcheva, A. ^{[2
]}

Sieper, J. ^{[4
]}

机构：

[1] Univ Alberta, Edmonton, AB, Canada

[2] Merck & Co Inc, Kenilworth, NJ USA

[3] Paris Descartes Univ, Paris, France

[4] Univ Clin Benjamin Franklin, Berlin, Germany

来源：

ANNALS OF THE RHEUMATIC DISEASES | 2015年 / 74卷

关键词：

D O I：

10.1136/annrheumdis-2015-eular.3046

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

AB0757

引用

页码：1151 / 1152

页数：2

共 50 条

[21] PATIENT-REPORTED QUALITY OF LIFE IN PATIENTS WITH BASELINE OBJECTIVE SIGNS OF INFLAMMATION AND ACTIVE NONRADIOGRAPHIC AXIAL SPONDYLOARTHRITIS TREATED WITH GOLIMUMAB: RESULTS OF THE OPEN-LABEL EXTENSION OF A RANDOMIZED, DOUBLE-BLIND STUDY
Maksymowych, W. P.
Dougados, M.
Sieper, J.
Braun, J.
Bergman, G.
Curtis, S. P.
Tzontcheva, A.
Philip, G.
Huyck, S.
van der Heijde, D.
ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 824 - 824
[22] PATIENT-REPORTED QUALITY OF LIFE IN PATIENTS WITH BASELINE OBJECTIVE SIGNS OF INFLAMMATION AND ACTIVE NONRADIOGRAPHIC AXIAL SPONDYLOARTHRITIS TREATED WITH GOLIMUMAB: RESULTS OF THE OPEN-LABEL EXTENSION OF A RANDOMIZED, DOUBLE-BLIND STUDY
Maksymowych, W. P.
Dougados, M.
Sieper, J.
Braun, J.
Bergman, G.
Curtis, S. P.
Tzontcheva, A.
Philip, G.
Huyck, S.
van der Heijde, D.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2016, 34 (04) : 781 - 781
[23] Golimumab in radiographic and nonradiographic axial spondyloarthritis: a review of clinical trials (vol 10, pg 2087, 2016)
Toussirot, E.
Vauchy, C.
Binda, D.
Michel, F.
DRUG DESIGN DEVELOPMENT AND THERAPY, 2017, 11 : 175 - 175
[24] Sexual Quality of Life in Patients with Axial Spondyloarthritis in the Biologic Treatment Era
Berg, Kari Hansen
Rohde, Gudrun Elin
Proven, Anne
Benestad, Esben Esther Pirelli
Ostensen, Monika
Haugeberg, Glenn
JOURNAL OF RHEUMATOLOGY, 2019, 46 (09) : 1075 - 1083
[25] Optimal concentration range of golimumab in patients with axial spondyloarthritis
Martinez-Feito, A.
Plasencia-Rodriguez, C.
Navarro-Compan, V.
Jurado, T.
Kneepkens, E. L.
Wolbink, G. J.
Martin, S.
Ruiz del Agua, A.
Navarro, R.
Mezcua, A.
Jochems, A.
Peiteado, D.
Bonilla, M. G.
Balsa, A.
Pascual-Salcedo, D.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2018, 36 (01) : 110 - 114
[26] EFFICACY OF GOLIMUMAB FOR NONRADIOGRAPHIC AXIAL SPONDYLOARTHRITIS: SUBGROUP ANALYSIS BY BASELINE MRI AND C-REACTIVE PROTEIN STATUS
Sieper, J.
van der Heijde, D.
Maksymowych, W. P.
Braun, J.
Bergman, G.
Curtis, S. P.
Tzontcheva, A.
Philip, G.
Huyck, S.
Dougados, M.
ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 813 - 814
[27] Ixekizumab Treatment Improves Fatigue, Spinal Pain, Stiffness, and Sleep in Patients with Nonradiographic Axial Spondyloarthritis
Mease, Philip
Deodhar, Atul
Rahman, Proton
Marzo-Ortega, Helena
Strand, Vibeke
Hunter, Theresa
Adams, David
Sandoval, David
Kronbergs, Andris
Zhu, Baojin
Leung, Ann
Liu-Leage, Soyi
Navarro-Compan, Victoria
ARTHRITIS & RHEUMATOLOGY, 2020, 72
[28] Sustained Improvement in Physical Function, Health-Related Quality of Life, and Work Productivity with Adalimumab Treatment in NonRadiographic Axial Spondyloarthritis.
van der Heijde, Desiree
Mittal, Manish
Chen, Naijun
Pangan, Aileen L.
Joshi, Avani D.
ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S242 - S242
[29] Efficacy of Ixekizumab on Disease Activity and Quality of Life in Patients with Active Nonradiographic Axial Spondyloarthritis and Objective Signs of Inflammation, Stratified by Baseline CRP/Sacroiliac Joint MRI Status
Maksymowych, Walter
Marzo-Ortega, Helena
Ostergaard, Mikkel
Gensler, Lianne
Ermann, Joerg
Deodhar, Atul
Poddubnyy, Denis
Sandoval, David
Bolce, Rebecca
Kronbergs, Andris
Liu-Leage, Soyi
Doridot, Gabriel
Geneus, Vladimir
Leung, Ann
Adams, David
Rudwaleit, Martin
ARTHRITIS & RHEUMATOLOGY, 2020, 72
[30] What determines the Quality of Life of Patients with axial Spondyloarthritis?
Kessing, Richard
AKTUELLE RHEUMATOLOGIE, 2018, 43 (05)

← 1 2 3 4 5 →